beta-CCB (cas# 84454-35-3) is a useful research chemical. beta-CCB has proconvulsant and anxiogenic effects, and it is an endogenous benzodiazepine binding inhibitor from brain.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.